Skip to main content
. 2020 Apr 19;28(9):4019–4029. doi: 10.1007/s00520-020-05440-x

Fig 1.

Fig 1

Images of MRONJ (a) after tooth extraction of upper first molar in a 55-year-old woman with lung cancer treated with bevacizumab (VEGF inhibitor), (b) another patient with MRONJ before and (c) after treatment (i.e., healthy tissue), and (d) the possible signs and symptoms of MRONJ (modified from [17]) MRONJ, medication-related osteonecrosis of the jaw; VEGF, vascular endothelial growth factor. Images courtesy of Morten Schiødt